Back to results
US 7,547,724 B2Granted
IAP BIR domain binding compounds
AssigneeAegera Therpeutics, Inc.
InventorsAlain Laurent, Kim E. Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
Life of this patent
Estimating the term…
Abstract
Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
Claims15
A compound represented by formula:
- or a salt thereof,
- wherein:
- m is 0, 1 or 2;
- p is 1 or 2;
- Y is NH, O or S;
- A and A1 are independently selected from
- 1) —CH2—,
- 2) —CH2CH2—,
- 3) —C(CH3)2—,
- 4) —CH(C1-C6 alkyl)-,
- 5) —CH(C3-C7 cycloalkyl)-,
- 6) —C3-C7 cycloalkyl-,
- 7) —CH(C1-C6 alkyl-C3-C7 cycloalkyl)-, or
- 8) —C(O)—;
- B and B1 are independently C1-C6 alkyl;
- X and X1 are independently selected from
- R1, R100, R2 and R200 are independently selected from:
- 1) H, or
- 2) C1-C6 alkyl optionally substituted with one or more R6 substituents;
- Q and Q1 are each independently
- 1) NR4R5,
- 2) OR11, or
- 3) S(O)mR11;
- or
- Q and Q1 are each independently
- wherein G is a 5, 6 or 7 membered ring which optionally incorporates one or more heteroatoms chosen from S, N or O, the ring being optionally substituted with one or more R12 substituents;
- R4 and R5 are each independently
- 1) H,
- 2) haloalkyl,
- 3) C1-C6 alkyl,
- 4) C2-C6 alkenyl,
- 5) C2-C4 alkynyl,
- 6) C3-C7 cycloalkyl,
- 7) C3-C7 cycloalkenyl,
- 8) aryl,
- 9) heteroaryl,
- 10) heterocyclyl,
- 11) heterobicyclyl,
- 12) C(O)—R11,
- 13) C(O)O—R11,
- 14) C(═Y)NR8R9, or
- 15) S(O)2—R11,
- wherein the alkyl, alkenyl, alkynyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more R6 substituents;
- and wherein the aryl, heteroaryl, heterocyclyl, and heterobicyclyl is optionally substituted with one or more R10 substituents;
- R6 is
- 1) halogen,
- 2) NO2,
- 3) CN,
- 4) haloalkyl,
- 5) C1-C6 alkyl,
- 6) C2-C6 alkenyl,
- 7) C2-C4 alkynyl,
- 8) C3-C7 cycloalkyl,
- 9) C3-C7 cycloalkenyl,
- 10) aryl,
- 11) heteroaryl,
- 12) heterocyclyl,
- 13) heterobicyclyl,
- 14) OR 7,
- 15) S(O)mR7,
- 16) NR8R9,
- 17) NR8S(O)2R11,
- 18) COR7,
- 19) C(O)OR7,
- 20) CONR8R9,
- 21) S(O)2NR8R9
- 22) OC(O)R7,
- 23) OC(O)Y—R11,
- 24) SC(O)R7, or
- 25) NC(Y)NR8R9,
- wherein the aryl, heteroaryl, heterocyclyl, and heterobicyclyl is optionally substituted with one or more R10 substituents;
- R7 is
- 1) H,
- 2) haloalkyl,
- 3) C1-C6 alkyl,
- 4) C2-C6 alkenyl,
- 5) C2-C4 alkynyl,
- 6) C3-C7 cycloalkyl,
- 7) C3-C7 cycloalkenyl,
- 8) aryl,
- 9) heteroaryl,
- 10) heterocyclyl,
- 11) heterobicyclyl,
- 12) R8R9NC(═Y), or
- 13) C1-C6 alkyl-C2-C4 alkenyl, or
- 14) C1-C6 alkyl-C2-C4 alkynyl,
- wherein the alkyl, alkenyl, alkynyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more R6 substituents;
- and wherein the aryl, heteroaryl, heterocyclyl, and heterobicyclyl is optionally substituted with one or more R10 substituents;
- R8 and R9 are each independently
- 1) H,
- 2) haloalkyl,
- 3) C1-C6 alkyl,
- 4) C2-C6 alkenyl,
- 5) C2-C4 alkynyl,
- 6) C3-C7 cycloalkyl,
- 7) C3-C7 cycloalkenyl,
- 8) aryl,
- 9) heteroaryl,
- 10) heterocyclyl,
- 11) heterobicyclyl,
- 12) C(O)R11,
- 13) C(O)Y—R11, or
- 14) S(O)2—R11,
- wherein the alkyl, alkenyl, alkynyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more R6 substituents;
- and wherein the aryl, heteroaryl, heterocyclyl, and heterobicyclyl is optionally substituted with one or more R10 substituents;
- or R8 and R9 together with the nitrogen atom to which they are bonded form a five, six or seven membered heterocyclic ring optionally substituted with one or more R6 substituents;
- R10 is
- 1) halogen,
- 2) NO2,
- 3) CN,
- 4) B(OR13)(OR14),
- 5) C1-C6 alkyl,
- 6) C2-C6 alkenyl,
- 7) C2-C4 alkynyl,
- 8) C3-C7 cycloalkyl,
- 9) C3-C7 cycloalkenyl,
- 10) haloalkyl,
- 11) OR7,
- 12) NR8R9,
- 13) SR7,
- 14) COR7,
- 15) C(O)OR7,
- 16) S(O)mR7,
- 17) CONR8R9,
- 18) S(O)2NR8R9,
- 19) aryl,
- 20) heteroaryl,
- 21) heterocyclyl, or
- 22) heterobicyclyl,
- wherein the alkyl, alkenyl, alkynyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more R6 substituents;
- R11 is
- 1) haloalkyl,
- 2) C1-C6 alkyl,
- 3) C2-C6 alkenyl,
- 4) C2-C4 alkynyl,
- 5) C3-C7 cycloalkyl,
- 6) C3-C7 cycloalkenyl,
- 7) aryl,
- 8) heteroaryl,
- 9) heterocyclyl, or
- 10) heterobicyclyl,
- wherein the alkyl, alkenyl, alkynyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more R6 substituents;
- and wherein the aryl, heteroaryl, heterocyclyl, and heterobicyclyl is optionally substituted with one or more R10 substituents;
- R12 is
- 1) haloalkyl,
- 2) C1-C6 alkyl,
- 3) C2-C6 alkenyl,
- 4) C2-C4 alkynyl,
- 5) C3-C7 cycloalkyl,
- 6) C3-C7 cycloalkenyl,
- 7) aryl,
- 8) heteroaryl,
- 9) heterocyclyl,
- 10) heterobicyclyl,
- 11) C(O)—R11,
- 12) C(O)O—R11,
- 13) C(O)NR8R9,
- 14) S(O)m—R11, or
- 15) C(═Y)NR8R9,
- wherein the alkyl, alkenyl, alkynyl, cycloalkyl, and cycloalkenyl is optionally substituted with one or more R6 substituents;
- and wherein the aryl, heteroaryl, heterocyclyl, and heterobicyclyl is optionally substituted with one or more R10 substituents;
- R13 and R14 are each independently
- 1) H, or
- 2) C1-C6 alkyl;
- or
- R13 and R14 are combined to form a heterocyclic ring or a heterobicyclic ring.
163 more elements
Dependencies are inferred from the claim text.